Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cortisone Infiltration and Mild Arthrographic Distension for Hemiparetic Shoulder Pain
NCT05845125Phase 4Terminated
- Start
- May 2023
- Primary completion
- May 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label trial of triamcinolone in shoulder pain (2 arms). Primary endpoints: Pain during activities of daily living and Pain at night or at rest. Started May 2023; status: terminated.
02
Drugs
triamcinolone
03
Conditions
shoulder pain
Beyond the preview
Go deeper on NCT05845125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05845125.